{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:28:56Z","timestamp":1791829736032,"version":"4.3.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T00:00:00Z","timestamp":1561420800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T00:00:00Z","timestamp":1561420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Heart Fail Rep"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s11897-019-00432-3","type":"journal-article","created":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T09:10:47Z","timestamp":1561453847000},"page":"150-156","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["Updates on Heart Transplantation"],"prefix":"10.1007","volume":"16","author":[{"given":"Kevin S.","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle M.","family":"Kittleson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon A.","family":"Kobashigawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,25]]},"reference":[{"key":"432_CR1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1161\/CIRCULATIONAHA.117.029753","volume":"137","author":"J Stehlik","year":"2018","unstructured":"Stehlik J, Kobashigawa J, Hunt SA, Reichenspurner H, Kirklin JK. Honoring 50 years of clinical heart transplantation in circulation: in-depth state-of-the-art review. Circulation. 2018;137:71\u201387.","journal-title":"Circulation"},{"issue":"10","key":"432_CR2","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.healun.2017.07.019","volume":"36","author":"Lars H. Lund","year":"2017","unstructured":"\u2022 Lund LH, Khush KK, Cherikh WS, Goldfarb S, Kucheryavaya AY, Levvey BJ, et al. The registry of the International Society for Heart and Lung Transplantation: thirty-fourth adult heart transplantation report\u20142017; focus theme: allograft ischemic time. J Hear Lung Transplant. 2017;36:1037\u201346. \n                      https:\/\/doi.org\/10.1016\/j.healun.2017.07.019\n                      \n                    . This statement provides updated data regarding heart transplant donor and recipient demographics, outcomes, with an emphasis on the effect of allograft ischemic time on outcomes.","journal-title":"The Journal of Heart and Lung Transplantation"},{"key":"432_CR3","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/ajt.14561","volume":"18","author":"M Colvin","year":"2018","unstructured":"Colvin M, Smith JM, Hadley N, Skeans MA, Carrico R, Uccellini K, et al. OPTN\/SRTR 2016 annual data report: heart. Am J Transplant. 2018;18:291\u2013362. \n                      https:\/\/doi.org\/10.1111\/ajt.14561\n                      \n                    .","journal-title":"Am J Transplant"},{"key":"432_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ijid.2014.04.007","volume":"25","author":"G Albertoni","year":"2014","unstructured":"Albertoni G, Castelo Gir\u00e3o MJB, Schor N. Mini review: current molecular methods for the detection and quantification of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1. Int J Infect Dis. 2014;25:145\u20139.","journal-title":"Int J Infect Dis"},{"key":"432_CR5","doi-asserted-by":"crossref","unstructured":"Levitsky J, Formica RN, Bloom RD, Charlton M, Curry M, Friedewald J, Friedman J, Goldberg D, Hall S, Ison M, Kaiser T, Klassen D, Klintmalm G, Kobashigawa J, Liapakis A, O\u2019Conner K, Reese P, Stewart D, Terrault N, Theodoropoulos N, Trotter J, Verna E, Volk M. The American Society of Transplantation consensus conference on the use of hepatitis C Viremic donors in solid organ transplantation. In: American Journal of Transplantation. 2017.","DOI":"10.1111\/ajt.14381"},{"key":"432_CR6","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1056\/NEJMoa1402355","volume":"370","author":"KV Kowdley","year":"2014","unstructured":"Kowdley KV, Gordon SC, Reddy KR, Rossaro L, Bernstein DE, Lawitz E, et al. Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis. N Engl J Med. 2014;370:1879\u201388. \n                      https:\/\/doi.org\/10.1056\/NEJMoa1402355\n                      \n                    .","journal-title":"N Engl J Med"},{"key":"432_CR7","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1111\/j.1600-6143.2010.03280.x","volume":"10","author":"JM Morales","year":"2010","unstructured":"Morales JM, Campistol JM, Dom\u00ednguez-Gil B, Andr\u00e9s A, Esforzado N, Oppenheimer F, et al. Long-term experience with kidney transplantation from hepatitis C-positive donors into hepatitis c-positive recipients. Am J Transplant. 2010;10:2453\u201362. \n                      https:\/\/doi.org\/10.1111\/j.1600-6143.2010.03280.x\n                      \n                    .","journal-title":"Am J Transplant"},{"key":"432_CR8","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1111\/ajt.13620","volume":"16","author":"D Sawinski","year":"2016","unstructured":"Sawinski D, Kaur N, Ajeti A, Trofe-Clark J, Lim M, Bleicher M, et al. Successful treatment of hepatitis C in renal transplant recipients with direct-acting antiviral agents. Am J Transplant. 2016;16:1588\u201395. \n                      https:\/\/doi.org\/10.1111\/ajt.13620\n                      \n                    .","journal-title":"Am J Transplant"},{"key":"432_CR9","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.healun.2018.01.1293","volume":"37","author":"KH Schlendorf","year":"2018","unstructured":"Schlendorf KH, Zalawadiya S, Shah AS, Wigger M, Chung CY, Smith S, et al. Early outcomes using hepatitis C\u2013positive donors for cardiac transplantation in the era of effective direct-acting anti-viral therapies. J Hear Lung Transplant. 2018;37:763\u20139. \n                      https:\/\/doi.org\/10.1016\/j.healun.2018.01.1293\n                      \n                    .","journal-title":"J Hear Lung Transplant"},{"key":"432_CR10","doi-asserted-by":"crossref","unstructured":"Kobashigawa J, Khush K, Colvin M, Acker M, Van Bakel A, Eisen H, Naka Y, Patel J, Baran DA, Daun T, Luu M, Olymbios M, Rogers J, Jeevanandam V, Esmailian F, Pagani FD, Lima B, Stehlik J. Report from the American Society of Transplantation conference on donor heart selection in adult cardiac transplantation in the United States. In: American Journal of Transplantation. 2017.","DOI":"10.1111\/ajt.14354"},{"key":"432_CR11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/ajt.13030","volume":"15","author":"DM Meyer","year":"2015","unstructured":"Meyer DM, Rogers JG, Edwards LB, Callahan ER, Webber SA, Johnson MR, et al. The future direction of the adult heart allocation system in the United States. Am J Transplant. 2015;15:44\u201354. \n                      https:\/\/doi.org\/10.1111\/ajt.13030\n                      \n                    .","journal-title":"Am J Transplant"},{"key":"432_CR12","doi-asserted-by":"crossref","unstructured":"Kobashigawa JA, Johnson M, Rogers J, Vega JD, Colvin-Adams M, Edwards L, Meyer D, Luu M, Reinsmoen N, Dipchand AI, Feldman D, Kormos R, Mancini D, Webber S. Report from a forum on US heart allocation policy. In: American Journal of Transplantation. 2015.","DOI":"10.1111\/ajt.13033"},{"key":"432_CR13","unstructured":"\u2022 Davies RR, Farr M, Silvestry S, Callahan LR, Edwards L, Meyer DM, et al. The new United States heart allocation policy: progress through collaborative revision. J Heart Lung Transplant. This article provides a summary of the rationale behind and the details regarding the heart allocation policy change within the U.S. 2017;36:595\u20136."},{"key":"432_CR14","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1016\/j.athoracsur.2007.05.095","volume":"84","author":"LU Nwakanma","year":"2007","unstructured":"Nwakanma LU, Williams JA, Weiss ES, Russell SD, Baumgartner WA, Conte JV. Influence of pretransplant panel-reactive antibody on outcomes in 8,160 heart transplant recipients in recent era. Ann Thorac Surg. 2007;84:1556\u201363. \n                      https:\/\/doi.org\/10.1016\/j.athoracsur.2007.05.095\n                      \n                    .","journal-title":"Ann Thorac Surg"},{"key":"432_CR15","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.healun.2010.08.020","volume":"30","author":"C Chin","year":"2011","unstructured":"Chin C, Chen G, Sequeria F, Berry G, Siehr S, Bernstein D, et al. Clinical usefulness of a novel C1q assay to detect immunoglobulin G antibodies capable of fixing complement in sensitized pediatric heart transplant patients. J Hear Lung Transplant. 2011;30:158\u201363. \n                      https:\/\/doi.org\/10.1016\/j.healun.2010.08.020\n                      \n                    .","journal-title":"J Hear Lung Transplant"},{"key":"432_CR16","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","volume":"369","author":"A Loupy","year":"2013","unstructured":"Loupy A, Lefaucheur C, Vernerey D, Prugger C, van Huyen J-PD, Mooney N, et al. Complement-binding anti-hla antibodies and kidney-allograft survival. N Engl J Med. 2013;369:1215\u201326. \n                      https:\/\/doi.org\/10.1056\/NEJMoa1302506\n                      \n                    .","journal-title":"N Engl J Med"},{"key":"432_CR17","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jacc.2016.04.033","volume":"68","author":"S Chih","year":"2016","unstructured":"Chih S, Chong AY, Mielniczuk LM, Bhatt DL, Beanlands RSB. Allograft vasculopathy the Achilles\u2019 heel of heart transplantation. J Am Coll Cardiol. 2016;68:80\u201391.","journal-title":"J Am Coll Cardiol"},{"key":"432_CR18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s11936-015-0431-9","volume":"18","author":"RM Cole","year":"2016","unstructured":"Cole RM, Kobashigawa JA. Desensitization strategies pre- and post-cardiac transplantation. Curr Treat Options Cardiovasc Med. 2016;18:8.","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"432_CR19","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/MOT.0000000000000411","volume":"22","author":"D Geft","year":"2017","unstructured":"Geft D, Kobashigawa J. Current concepts for sensitized patients before transplantation. Curr Opin Organ Transplant. 2017;22:236\u201341.","journal-title":"Curr Opin Organ Transplant"},{"key":"432_CR20","doi-asserted-by":"publisher","first-page":"S187","DOI":"10.1016\/j.healun.2004.03.009","volume":"23","author":"H Valantine","year":"2004","unstructured":"Valantine H. Cardiac allograft vasculopathy after heart transplantation: risk factors and management. J Hear Lung Transpl. 2004;23:S187\u201393. \n                      https:\/\/doi.org\/10.1016\/j.healun.2004.03.009\n                      \n                    .","journal-title":"J Hear Lung Transpl"},{"key":"432_CR21","doi-asserted-by":"crossref","unstructured":"Chang DH, Kittleson MM, Kobashigawa JA. Immunosuppression following heart transplantation: prospects and challenges. Immunotherapy. 2014.","DOI":"10.2217\/imt.13.163"},{"key":"432_CR22","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1111\/ajt.12809","volume":"14","author":"AK Andreassen","year":"2014","unstructured":"Andreassen AK, Andersson B, Gustafsson F, Eiskj\u00e6r H, Gude E, Jansson K, et al. Everolimus initiation and early calcineurin inhibitor withdrawal in heart transplant recipients: a randomized trial. Am J Transplant. 2014;14:1828\u201338. \n                      https:\/\/doi.org\/10.1111\/ajt.12809\n                      \n                    .","journal-title":"Am J Transplant"},{"key":"432_CR23","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/tri.12309","volume":"27","author":"M Baraldo","year":"2014","unstructured":"Baraldo M, Gregoraci G, Livi U. Steroid-free and steroid withdrawal protocols in heart transplantation: the review of literature. Transpl Int. 2014;27:515\u201329.","journal-title":"Transpl Int"},{"key":"432_CR24","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.athoracsur.2006.03.067","volume":"82","author":"DH Rosenbaum","year":"2006","unstructured":"Rosenbaum DH, Adams BC, Mitchell JD, Jessen ME, Paul MC, Kaiser PA, et al. Effects of early steroid withdrawal after heart transplantation. Ann Thorac Surg. 2006;82:637\u201344. \n                      https:\/\/doi.org\/10.1016\/j.athoracsur.2006.03.067\n                      \n                    .","journal-title":"Ann Thorac Surg"},{"key":"432_CR25","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1161\/CIRCHEARTFAILURE.110.958520","volume":"4","author":"DA Baran","year":"2011","unstructured":"Baran DA, Zucker MJ, Arroyo LH, Camacho M, Goldschmidt ME, Nicholls SJ, et al. A prospective, randomized trial of single-drug versus dual-drug immunosuppression in heart transplantation: the tacrolimus in combination, tacrolimus alone compared (TICTAC) trial. Circ Hear Fail. 2011;4:129\u201337. \n                      https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.110.958520\n                      \n                    .","journal-title":"Circ Hear Fail"},{"key":"432_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0735-1097(92)90049-S","volume":"19","author":"JW Deckers","year":"1992","unstructured":"Deckers JW, Hare JM, Baughman KL. Complications of transvenous right ventricular endomyocardial biopsy in adult patients with cardiomyopathy: a seven-year survey of 546 consecutive diagnostic procedures in a tertiary referral center. J Am Coll Cardiol. 1992;19:43\u20137. \n                      https:\/\/doi.org\/10.1016\/0735-1097(92)90049-S\n                      \n                    .","journal-title":"J Am Coll Cardiol"},{"key":"432_CR27","doi-asserted-by":"publisher","first-page":"S219","DOI":"10.1016\/j.healun.2005.04.001","volume":"24","author":"CC Marboe","year":"2005","unstructured":"Marboe CC, Billingham M, Eisen H, Deng MC, Baron H, Mehra M, et al. Nodular endocardial infiltrates (Quilty lesions) cause significant variability in diagnosis of ISHLT grade 2 and 3A rejection in cardiac allograft recipients. J Heart Lung Transplant. 2005;24:S219\u201326.","journal-title":"J Heart Lung Transplant"},{"key":"432_CR28","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1093\/eurheartj\/ehv682","volume":"37","author":"MG Crespo-Leiro","year":"2016","unstructured":"Crespo-Leiro MG, Stypmann J, Schulz U, Zuckermann A, Mohacsi P, Bara C, et al. Clinical usefulness of gene-expression profile to rule out acute rejection after heart transplantation: CARGO II. Eur Heart J. 2016;37:2591\u2013601. \n                      https:\/\/doi.org\/10.1093\/eurheartj\/ehv682\n                      \n                    .","journal-title":"Eur Heart J"},{"issue":"20","key":"432_CR29","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1056\/NEJMoa0912965","volume":"362","author":"Michael X. Pham","year":"2010","unstructured":"\u2022\u2022 Pham MX, Teuteberg JJ, Kfoury AG, Starling RC, Deng MC, Cappola TP, et al. Gene-expression profiling for rejection surveillance after cardiac transplantation. N Engl J Med. 2010;362:1890\u2013900. \n                      https:\/\/doi.org\/10.1056\/NEJMoa0912965\n                      \n                    . This randomized trial demonstrated the noninferiority of a surviellance strategy utilizing gene expression profiling, as compared with routine biopsies, was not associated with an increased risk of serious adverse outcomes.","journal-title":"New England Journal of Medicine"},{"key":"432_CR30","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1161\/CIRCHEARTFAILURE.114.001658","volume":"8","author":"J Kobashigawa","year":"2015","unstructured":"Kobashigawa J, Patel J, Azarbal B, Kittleson M, Chang D, Czer L, et al. Randomized pilot trial of gene expression profiling versus heart biopsy in the first year after heart transplant: early invasive monitoring attenuation through gene expression trial. Circ Heart Fail. 2015;8:557\u201364. \n                      https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.114.001658\n                      \n                    .","journal-title":"Circ Heart Fail"},{"key":"432_CR31","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/S0140-6736(05)79055-3","volume":"351","author":"YMD Lo","year":"1998","unstructured":"Lo YMD, Tein MSC, Pang CCP, Yeung CK, Tong KL, Magnus Hjelm N. Presence of donor-specific DNA in plasma of kidney and liver-transplant recipients. Lancet. 1998;351:1329\u201330. \n                      https:\/\/doi.org\/10.1016\/S0140-6736(05)79055-3\n                      \n                    .","journal-title":"Lancet"},{"key":"432_CR32","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1373\/clinchem.2013.210328","volume":"59","author":"J Beck","year":"2013","unstructured":"Beck J, Bierau S, Balzer S, Andag R, Kanzow P, Schmitz J, et al. Digital droplet PCR for rapid quantification of donor DNA in the circulation of transplant recipients as a potential universal biomarker of graft injury. Clin Chem. 2013;59:1732\u201341. \n                      https:\/\/doi.org\/10.1373\/clinchem.2013.210328\n                      \n                    .","journal-title":"Clin Chem"},{"key":"432_CR33","doi-asserted-by":"publisher","first-page":"241ra77","DOI":"10.1126\/scitranslmed.3007803","volume":"6","author":"I De Vlaminck","year":"2014","unstructured":"De Vlaminck I, Valantine HA, Snyder TM, Strehl C, Cohen G, Luikart H, et al. Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection. Sci Transl Med. 2014;6:241ra77. \n                      https:\/\/doi.org\/10.1126\/scitranslmed.3007803\n                      \n                    .","journal-title":"Sci Transl Med"},{"key":"432_CR34","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/ki.2013.300","volume":"85","author":"PF Halloran","year":"2014","unstructured":"Halloran PF, Reeve JP, Pereira AB, Hidalgo LG, Famulski KS. Antibody-mediated rejection, T cell-mediated rejection, and the injury-repair response: new insights from the Genome Canada studies of kidney transplant biopsies. Kidney Int. 2014;85:258\u201364. \n                      https:\/\/doi.org\/10.1038\/ki.2013.300\n                      \n                    .","journal-title":"Kidney Int"},{"key":"432_CR35","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1111\/j.1600-6143.2010.03182.x","volume":"10","author":"M Mengel","year":"2010","unstructured":"Mengel M, Sis B, Kim D, Chang J, Famulski KS, Hidalgo LG, et al. The molecular phenotype of heart transplant biopsies: relationship to histopathological and clinical variables. Am J Transplant. 2010;10:2105\u201315. \n                      https:\/\/doi.org\/10.1111\/j.1600-6143.2010.03182.x\n                      \n                    .","journal-title":"Am J Transplant"},{"key":"432_CR36","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.healun.2017.05.029","volume":"36","author":"PF Halloran","year":"2017","unstructured":"Halloran PF, Potena L, Van Huyen JPD, Bruneval P, Leone O, Kim DH, et al. Building a tissue-based molecular diagnostic system in heart transplant rejection: the heart molecular microscope diagnostic (MMDx) system. J Heart Lung Transplant. 2017;36:1192\u2013200. \n                      https:\/\/doi.org\/10.1016\/j.healun.2017.05.029\n                      \n                    .","journal-title":"J Heart Lung Transplant"},{"key":"432_CR37","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/ccd.27164","volume":"90","author":"JM Tobis","year":"2017","unstructured":"Tobis JM. Cardiac transplant vasculopathy. Catheter Cardiovasc Interv. 2017;90:56\u20137.","journal-title":"Catheter Cardiovasc Interv"},{"key":"432_CR38","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.healun.2013.08.006","volume":"32","author":"LH Lund","year":"2013","unstructured":"Lund LH, Edwards LB, Kucheryavaya AY, Dipchand AI, Benden C, Christie JD, et al. The registry of the International Society for Heart and Lung Transplantation: thirtieth official adult heart transplant report - 2013; focus theme: Age. J Hear Lung Transplant. 2013;32:951\u201364. \n                      https:\/\/doi.org\/10.1016\/j.healun.2013.08.006\n                      \n                    .","journal-title":"J Hear Lung Transplant"},{"key":"432_CR39","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1016\/j.jacc.2005.02.035","volume":"45","author":"JA Kobashigawa","year":"2005","unstructured":"Kobashigawa JA, Tobis JM, Starling RC, Tuzcu EM, Smith AL, Valantine HA, et al. Multicenter intravascular ultrasound validation study among heart transplant recipients: outcomes after five years. J Am Coll Cardiol. 2005;45:1532\u20137.","journal-title":"J Am Coll Cardiol"},{"key":"432_CR40","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1016\/j.jacc.2014.01.071","volume":"63","author":"O Wever-Pinzon","year":"2014","unstructured":"Wever-Pinzon O, Romero J, Kelesidis I, Wever-Pinzon J, Manrique C, Budge D, et al. Coronary computed tomography angiography for the detection of cardiac allograft vasculopathy: a meta-analysis of prospective trials. J Am Coll Cardiol. 2014;63:2005\u20136. \n                      https:\/\/doi.org\/10.1016\/j.jacc.2014.01.071\n                      \n                    .","journal-title":"J Am Coll Cardiol"}],"container-title":["Current Heart Failure Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-019-00432-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11897-019-00432-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-019-00432-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T19:25:25Z","timestamp":1592940325000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11897-019-00432-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,25]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["432"],"URL":"https:\/\/doi.org\/10.1007\/s11897-019-00432-3","relation":{},"ISSN":["1546-9530","1546-9549"],"issn-type":[{"value":"1546-9530","type":"print"},{"value":"1546-9549","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,25]]},"assertion":[{"value":"25 June 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Kevin S. Shah and Michelle M. Kittleson declare no conflicts of interest. Jon A. Kobashigawa reports grants from Novartis, grants from Alexion, grants and personal fees from CareDx, grants from Sanofi, all outside the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}